Excess Weight Can Make Frailty Worse
The study was funded by Novo Nordisk, the maker of the semaglutide drugs Ozempic and Wegovy, and several of the study’s researchers reported compensation from Novo. Still, healthcare providers say the findings make sense.
Much of the benefit comes from fat loss, according to Mir Ali, MD, the medical director of the MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California, who was not involved with the research. “The benefits of weight loss often outweigh the possible loss of muscle,” he says. “Frailty can actually improve with weight loss in people with…
Read the full article at EVERYDAYHEALTH.COM


